BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8540311)

  • 21. [H2 receptor blocker or prostaglandin E in ulcer therapy?].
    Forth W
    Klin Wochenschr; 1986 Sep; 64(17):806-9. PubMed ID: 2876129
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effects of nizatidine and misoprostol on peptic activity and gastric mucus].
    Grassi SA; Vianello F; Germanà B; Dal Santo P; Faggian D; Battaglia G; Plebani M; Di Mario F; Naccarato R
    Medicina (Firenze); 1990; 10(1):29-31. PubMed ID: 1974318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L
    Gac Med Mex; 1981 Dec; 117(12):472-4. PubMed ID: 6123460
    [No Abstract]   [Full Text] [Related]  

  • 24. High IgE serum levels and "peptic" ulcers: clinical and functional approach.
    De Lazzari F; Mancin O; Plebani M; Venturi C; Battaglia G; Vianello F; Galliani EA; Di Mario F; Naccarato R
    Ital J Gastroenterol; 1994; 26(1):7-11. PubMed ID: 7912969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indications and successes of conservative therapy in gastroenterology: peptic ulcer].
    Gugler R
    Z Gastroenterol Verh; 1989 Jul; 24():82-4. PubMed ID: 2474995
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage.
    Tanaka Y; Mine K; Nakai Y; Mishima N; Nakagawa T
    Gut; 1991 Aug; 32(8):849-52. PubMed ID: 1885064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer].
    Glubochenko VG; Shcherbak VV
    Vrach Delo; 1985 Feb; (2):13-5. PubMed ID: 2859701
    [No Abstract]   [Full Text] [Related]  

  • 29. Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters.
    Am J Gastroenterol; 1988 Jun; 83(6):607-17. PubMed ID: 2897783
    [No Abstract]   [Full Text] [Related]  

  • 30. [Indications for anti-ulcer drugs in adults].
    Chassany O
    Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long-term drug therapy of ulcer disease. Findings for deciding, indications, duration and surgical alternatives].
    Peitsch W
    Fortschr Med; 1986 Sep; 104(36):681-4. PubMed ID: 2876940
    [No Abstract]   [Full Text] [Related]  

  • 34. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
    Matsukawa Y; Nishinarita S; Kaneko M; Takei M; Murakami M; Horie T; Kawamura F; Arakawa Y; Kuwayama H; Kurosaka H
    Int J Clin Pharmacol Res; 1997; 17(4):127-32. PubMed ID: 9526173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptic ulcer. A follow-up study.
    Bank L; Wright JP; Lucke W; Marks IN
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):381-4. PubMed ID: 2876024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conservative treatment of ulcer hemorrhage with histamine H2 antagonists].
    Grigor'ev PI; Grinberg AA; Toguzova DA; Iakovenko AV; Lopatina IV
    Khirurgiia (Mosk); 1997; (5):63-5. PubMed ID: 9297029
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gastroduodenal ulcer--changes in surgical therapy by long-term drug treatment].
    Peitsch W
    Zentralbl Chir; 1986; 111(23):1433-40. PubMed ID: 2881413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs for peptic ulcer. Invited commentary.
    Grossman MI
    World J Surg; 1977 Jan; 1(1):7-8. PubMed ID: 17231
    [No Abstract]   [Full Text] [Related]  

  • 39. Pepsinogens, pepsins, and peptic ulcer.
    Samloff IM; Taggart RT
    Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.